Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Takeda reports oral cephem antibacterials

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Allergan claims retinoid-like compounds for dermatologic indications

May 17, 1996

Pfizer claims analgesic bradykinin antagonists

May 17, 1996

Sandoz synthesizes new antidiabetic agents

May 10, 1996

Potential pancreatitis treatments reported by Snow Brand

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

More Na+/H+-exchange inhibitors from Hoechst

May 10, 1996

Na+/H+-exchange inhibitors revealed by E. Merck

May 10, 1996

5-HT2 antagonists claimed by Toa Eiyo

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...